Physical activity, by enhancing parasympathetic tone and activating the cholinergic anti-inflammatory pathway, is a therapeutic strategy to restrain chronic inflammation and prevent many chronic diseases

Medical Hypotheses

Volumn 80, Issue 5, 2013, Pages 548-552

  Lujan, Heidi L ^a   DiCarlo, Stephen E ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; NICOTINE;

ARTICLE; CHOLINERGIC ACTIVITY; CHRONIC DISEASE; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; EXERCISE; HUMAN; IMMUNOMODULATION; NONHUMAN; PARASYMPATHETIC FUNCTION; PARASYMPATHETIC TONE; PHYSICAL ACTIVITY; SEDENTARY LIFESTYLE; SMOKING; THERAPY EFFECT;

CHOLINERGIC FIBERS; CHRONIC DISEASE; CYTOKINES; GANGLIA, PARASYMPATHETIC; HUMANS; INFLAMMATION; MODELS, IMMUNOLOGICAL; MOTOR ACTIVITY; SIGNAL TRANSDUCTION;

EID: 84875590954     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.01.014     Document Type: Article

References (102)

1. Antonica A., Magni F., Mearini L., Paolocci N. Vagal control of lymphocyte release from rat thymus. J Auton Nerv Syst 1994, 48:187-197.
2. Aubert A.E., Seps B., Beckers F. Heart rate variability in athletes. Sports Med 2003, 33:889-919.
3. Barbash G.I., Reiner J., White H.D., Wilcox R.G., Armstrong P.W., Sadowski Z., et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the " smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global utilization of streptokinase and tissue-plasminogen activator for occluded coronary arteries. J Am Coll Cardiol 1995, 26:1222-1229.
4. Barbash G.I., White H.D., Modan M., Diaz R., Hampton J.R., Heikkila J., et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial. Circulation 1993, 87:53-58.
5. Barbeau P., Litaker M.S., Woods K.F., Lemmon C.R., Humphries M.C., Owens S., et al. Hemostatic and inflammatory markers in obese youths: effects of exercise and adiposity. J Pediatr 2002, 141:415-420.
6. Barzilay J.I., Abraham L., Heckbert S.R., Cushman M., Kuller L.H., Resnick H.E., et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study. Diabetes 2001, 50:2384-2389.
7. Bibevski S., Dunlap M.E. Prevention of diminished parasympathetic control of the heart in experimental heart failure. Am J Physiol Heart Circ Physiol 2004, 287:H1780-H1785.
8. Billman G.E. Aerobic exercise conditioning: a nonpharmacological antiarrhythmic intervention. J Appl Physiol 2002, 92:446-454.
9. Billman G.E. A comprehensive review and analysis of 25years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development. Pharmacol Ther 2006, 111:808-835.
10. Blair S.N. Physical inactivity: the biggest public health problem of the 21st century. Br J Sports Med 2009, 43:1-2.
11. Blair S.N., Cheng Y., Holder J.S. Is physical activity or physical fitness more important in defining health benefits?. Med Sci Sports Exerc 2001, 33:S379-S399.
12. Blomqvist C.G., Saltin B. Cardiovascular adaptations to physical training. Annu Rev Physiol 1983, 45:169-189.
13. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
14. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol 2005, 78:819-835.
15. Buch A.N., Coote J.H., Townend J.N. Mortality, cardiac vagal control and physical training - what's the link?. Exp Physiol 2002, 87:423-435.
16. Buchheit M., Millet G.P., Parisy A., Pourchez S., Laursen P.B., Ahmaidi S. Supramaximal training and postexercise parasympathetic reactivation in adolescents. Med Sci Sports Exerc 2008, 40:362-371.
17. Calvillo L., Vanoli E., Andreoli E., Besana A., Omodeo E., Gnecchi M., et al. Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 2011, 58:500-507.
18. Colbert L.H., Visser M., Simonsick E.M., Tracy R.P., Newman A.B., Kritchevsky S.B., et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the health, aging and body composition study. J Am Geriatr Soc 2004, 52:1098-1104.
19. de Schryver C., Mertens-Strythagen J. Heart tissue acetylcholine in chronically exercised rats. Experientia 1975, 31:316-318.
20. DiPenta J.M., Johnson J.G., Murphy R.J. Natural killer cells and exercise training in the elderly: a review. Can J Appl Physiol 2004, 29:419-443.
21. Duncan B.B., Schmidt M.I., Pankow J.S., Ballantyne C.M., Couper D., Vigo A., et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003, 52:1799-1805.
22. Dunlap M.E. Doing the right thing. J Am Coll Cardiol 2011, 58:887.
23. Dunn A.L., Trivedi M.H., Kampert J.B., Clark C.G., Chambliss H.O. Exercise treatment for depression: efficacy and dose response. Am J Prev Med 2005, 28:1-8.
24. Dunstan D.W., Barr E.L., Healy G.N., Salmon J., Shaw J.E., Balkau B., et al. Television viewing time and mortality: the Australian diabetes, obesity and lifestyle study (AusDiab). Circulation 2010, 121:384-391.
25. Edwards T. Inflammation, pain, and chronic disease: an integrative approach to treatment and prevention. Altern Ther Health Med 2005, 11:20-27.
26. Erikssen G., Liestol K., Bjornholt J., Thaulow E., Sandvik L., Erikssen J. Changes in physical fitness and changes in mortality. Lancet 1998, 352:759-762.
27. Festa A., D'Agostino R., Tracy R.P., Haffner S.M. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002, 51:1131-1137.
28. Fleshner M., Goehler L.E., Schwartz B.A., McGorry M., Martin D., Maier S.F., et al. Thermogenic and corticosterone responses to intravenous cytokines (IL-1beta and TNF-alpha) are attenuated by subdiaphragmatic vagotomy. J Neuroimmunol 1998, 86:134-141.
29. Fonarow G.C., Abraham W.T., Albert N.M., Stough W.G., Gheorghiade M., Greenberg B.H., et al. A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF. Eur Heart J 2008, 29:1983-1991.
30. Ford E.S. Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am J Epidemiol 2002, 155:57-64.
31. Ford E.S., Kohl H.W., Mokdad A.H., Ajani U.A. Sedentary behavior, physical activity, and the metabolic syndrome among US adults. Obes Res 2005, 13:608-614.
32. Freeman D.J., Norrie J., Caslake M.J., Gaw A., Ford I., Lowe G.D., et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the west of Scotland coronary prevention study. Diabetes 2002, 51:1596-1600.
33. Fung T.T., Hu F.B., Yu J., Chu N.F., Spiegelman D., Tofler G.H., et al. Leisure-time physical activity, television watching, and plasma biomarkers of obesity and cardiovascular disease risk. Am J Epidemiol 2000, 152:1171-1178.
34. Gallowitsch-Puerta M., Pavlov V.A. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci 2007, 80:2325-2329.
35. Gaykema R.P., Dijkstra I., Tilders F.J. Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology 1995, 136:4717-4720.
36. Genovesi S., Zaccaria D., Rossi E., Valsecchi M.G., Stella A., Stramba-Badiale M. Effects of exercise training on heart rate and QT interval in healthy young individuals: are there gender differences?. Europace 2007, 9:55-60.
37. Gleeson M. Immune function in sport and exercise. J Appl Physiol 2007, 103:693-699.
38. Goldhammer E., Tanchilevitch A., Maor I., Beniamini Y., Rosenschein U., Sagiv M. Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 2005, 100:93-99.
39. Goldsmith R.L., Bigger J.T., Steinman R.C., Fleiss J.L. Comparison of 24-h parasympathetic activity in endurance-trained and untrained young men. J Am Coll Cardiol 1992, 20:552-558.
40. Gourlay S.G., Rundle A.C., Barron H.V. Smoking and mortality following acute myocardial infarction: results from the national registry of myocardial infarction 2 (NRMI 2). Nicotine Tob Res 2002, 4:101-107.
41. Guslandi M. Nicotine treatment for ulcerative colitis. Br J Clin Pharmacol 1999, 48:481-484.
42. Haffner S.M. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006, 97:3A-11A.
43. Hamburg N.M., McMackin C.J., Huang A.L., Shenouda S.M., Widlansky M.E., Schulz E., et al. Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers. Arterioscler Thromb Vasc Biol 2007, 27:2650-2656.
44. Han T.S., Sattar N., Williams K., Gonzalez-Villalpando C., Lean M.E., Haffner S.M. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico city diabetes study. Diabetes Care 2002, 25:2016-2021.
45. Hasdai D., Lerman A., Rihal C.S., Criger D.A., Garratt K.N., Betriu A., et al. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. Am Heart J 1999, 137:612-620.
46. He J., Ogden L.G., Bazzano L.A., Vupputuri S., Loria C., Whelton P.K. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001, 161:996-1002.
47. Healy G.N., Wijndaele K., Dunstan D.W., Shaw J.E., Salmon J., Zimmet P.Z., et al. Objectively measured sedentary time, physical activity, and metabolic risk: the Australian diabetes, obesity and lifestyle study (AusDiab). Diabetes Care 2008, 31:369-371.
48. Hillman C.H., Castelli D.M., Buck S.M. Aerobic fitness and neurocognitive function in healthy preadolescent children. Med Sci Sports Exerc 2005, 37:1967-1974.
49. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
50. Hu F.B., Willett W.C., Li T., Stampfer M.J., Colditz G.A., Manson J.E. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 2004, 351:2694-2703.
51. Jae S.Y., Fernhall B., Heffernan K.S., Jeong M., Chun E.M., Sung J., et al. Effects of lifestyle modifications on C-reactive protein: contribution of weight loss and improved aerobic capacity. Metabolism 2006, 55:825-831.
52. Jakes R.W., Day N.E., Khaw K.T., Luben R., Oakes S., Welch A., et al. Television viewing and low participation in vigorous recreation are independently associated with obesity and markers of cardiovascular disease risk: EPIC-Norfolk population-based study. Eur J Clin Nutr 2003, 57:1089-1096.
53. Kasapis C., Thompson P.D. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005, 45:1563-1569.
54. Katzmarzyk P.T., Church T.S., Craig C.L., Bouchard C. Sitting time and mortality from all causes, cardiovascular disease, and cancer. Med Sci Sports Exerc 2009, 41:998-1005.
55. Kelly T.L., Gilpin E., Ahnve S., Henning H., Ross J. Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J 1985, 110:535-541.
56. Khansari N., Shakiba Y., Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 2009, 3:73-80.
57. Kohut M.L., Senchina D.S. Reversing age-associated immunosenescence via exercise. Exerc Immunol Rev 2004, 10:6-41.
58. Kokkinos P., Myers J., Kokkinos J.P., Pittaras A., Narayan P., Manolis A., et al. Exercise capacity and mortality in black and white men. Circulation 2008, 117:614-622.
59. Lichodziejewska B., Kurnicka K., Grudzka K., Malysz J., Ciurzynski M., Liszewska-Pfejfer D. Chronic and acute effects of smoking on left and right ventricular relaxation in young healthy smokers. Chest 2007, 131:1142-1148.
60. Lindsay R.S., Funahashi T., Hanson R.L., Matsuzawa Y., Tanaka S., Tataranni P.A., et al. Adiponectin and development of type 2 diabetes in the pima Indian population. Lancet 2002, 360:57-58.
61. Maciel B.C., Gallo Junior L., Marin Neto J.A., Lima Filho E.C., Terra Filho J., Manco J.C. Parasympathetic contribution to bradycardia induced by endurance training in man. Cardiovasc Res 1985, 19:642-648.
62. Manzi V., Castagna C., Padua E., Lombardo M., D'Ottavio S., Massaro M., et al. Dose-response relationship of autonomic nervous system responses to individualized training impulse in marathon runners. Am J Physiol Heart Circ Physiol 2009, 296:H1733-H1740.
63. Matter C.M., Handschin C. RANTES (regulated on activation, normal T cell expressed and secreted), inflammation, obesity, and the metabolic syndrome. Circulation 2007, 115:946-948.
64. Mattusch F., Dufaux B., Heine O., Mertens I., Rost R. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 2000, 21:21-24.
65. Murphy K, Topel R. The value of health and longevity. in: NBER Working Papers Series No. 11405. Cambridge: National Bureau of Economic Research; 2005.
66. Nakanishi N., Yoshida H., Matsuo Y., Suzuki K., Tatara K. White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men. Diabetologia 2002, 45:42-48.
67. Narula N., Fedorak R.N. Exercise and inflammatory bowel disease. Can J Gastroenterol 2008, 22:497-504.
68. Nicolozakes A.W., Binkley P.F., Leier C.V. Hemodynamic effects of smoking in congestive heart failure. Am J Med Sci 1988, 296:377-380.
69. Nowak J., Murray J.J., Oates J.A., FitzGerald G.A. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 1987, 76:6-14.
70. Obisesan T.O., Leeuwenburgh C., Phillips T., Ferrell R.E., Phares D.A., Prior S.J., et al. C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels. Arterioscler Thromb Vasc Biol 2004, 24:1874-1879.
71. Ordway G.A., Charles J.B., Randall D.C., Billman G.E., Wekstein D.R. Heart rate adaptation to exercise training in cardiac-denervated dogs. J Appl Physiol 1982, 52:1586-1590.
72. Ovbiagele B., Saver J.L. The smoking-thrombolysis paradox and acute ischemic stroke. Neurology 2005, 65:293-295.
73. Pavlov V.A., Parrish W.R., Rosas-Ballina M., Ochani M., Puerta M., Ochani K., et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun 2009, 23:41-45.
74. Pavlov V.A., Tracey K.J. The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005, 19:493-499.
75. Petersen A.M., Pedersen B.K. The anti-inflammatory effect of exercise. J Appl Physiol 2005, 98:1154-1162.
76. Peto R., Lopez A.D., Boreham J., Thun M., Heath C. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992, 339:1268-1278.
77. Pocock S.J., Wang D., Pfeffer M.A., Yusuf S., McMurray J.J., Swedberg K.B., et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006, 27:65-75.
78. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
79. Rabinowitz B.D., Thorp K., Huber G.L., Abelmann W.H. Acute hemodynamic effects of cigarette smoking in man assessed by systolic time intervals and echocardiography. Circulation 1979, 60:752-760.
80. Rall L.C., Roubenoff R., Cannon J.G., Abad L.W., Dinarello C.A., Meydani S.N. Effects of progressive resistance training on immune response in aging and chronic inflammation. Med Sci Sports Exerc 1996, 28:1356-1365.
81. Romanovsky A.A., Simons C.T., Szekely M., Kulchitsky V.A. The vagus nerve in the thermoregulatory response to systemic inflammation. Am J Physiol 1997, 273:R407-R413.
82. Rowell L.B. Human Circulation Regulation During Physical Stress 1986, Oxford University Press, New York, p. 257-286.
83. Sallis R.E. Exercise is medicine and physicians need to prescribe it!. Br J Sports Med 2009, 43:3-4.
84. Sandborn W.J., Tremaine W.J., Offord K.P., Lawson G.M., Petersen B.T., Batts K.P., et al. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997, 126:364-371.
85. Schuit A.J., Dekker J.M., De V.F., Verheij T.C., Rijneke R.D., Schouten E.G. Effect of physical training on QTc interval in elderly people. J Electrocardiol 1998, 31:111-116.
86. Sher M.E., Bank S., Greenberg R., Sardinha T.C., Weissman S., Bailey B., et al. The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease. Inflamm Bowel Dis 1999, 5:73-78.
87. Sloan R.P., Shapiro P.A., DeMeersman R.E., Bagiella E., Brondolo E.N., McKinley P.S., et al. The effect of aerobic training and cardiac autonomic regulation in young adults. Am J Public Health 2009, 99:921-928.
88. Smith M.L., Hudson D.L., Graitzer H.M., Raven P.B. Exercise training bradycardia: the role of autonomic balance. Med Sci Sports Exerc 1989, 21:40-44.
89. Stewart K.J. Role of exercise training on cardiovascular disease in persons who have type 2 diabetes and hypertension. Cardiol Clin 2004, 22:569-586.
90. Suskin N., Sheth T., Negassa A., Yusuf S. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol 2001, 37:1677-1682.
91. Sylvestre-Gervais L., Nadeau A., Nguyen M.H., Tancrede G., Rousseau-Migneron S. Effects of physical training on beta-adrenergic receptors in rat myocardial tissue. Cardiovasc Res 1982, 16:530-534.
92. Tansey M.G., Frank-Cannon T.C., McCoy M.K., Lee J.K., Martinez T.N., McAlpine F.E., et al. Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?. Front Biosci 2008, 13:709-717.
93. Tsuchiya M., Asada A., Kasahara E., Sato E.F., Shindo M., Inoue M. Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 2002, 105:1155-1157.
94. Vozarova B., Weyer C., Lindsay R.S., Pratley R.E., Bogardus C., Tataranni P.A. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002, 51:455-461.
95. Warren T.Y., Barry V., Hooker S.P., Sui X., Church T.S., Blair S.N. Sedentary behaviors increase risk of cardiovascular disease mortality in men. Med Sci Sports Exerc 2010, 42:879-885.
96. Watkins L.R., Goehler L.E., Relton J.K., Tartaglia N., Silbert L., Martin D., et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett 1995, 183:27-31.
97. WHO. Physical Inactivity: A global public health problem. 2012. Accessed 09-2012. http://www.who.int/dietphysicalactivity/factsheet_inactivity/en/index.html.
98. Wick J.Y. Aspirin: a history, a love story. Consult Pharm 2012, 27:322-329.
99. Wilhelmsen L., Rosengren A., Eriksson H., Lappas G. Heart failure in the general population of men-morbidity, risk factors and prognosis. J Intern Med 2001, 249:253-261.
100. Woods J.A., Lowder T.W., Keylock K.T. Can exercise training improve immune function in the aged?. Ann NY Acad Sci 2002, 959:117-127.
101. Yanagibori R., Kondo K., Suzuki Y., Kawakubo K., Iwamoto T., Itakura H., et al. Effect of 20 days' bed rest on the reverse cholesterol transport system in healthy young subjects. J Intern Med 1998, 243:307-312.
102. Zipp F., Aktas O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci 2006, 29:518-527.